Heier Jeffrey S.

Chief Scientific Officer at OCUL

Sold, on record
$349k
Dollars the filings state
Form 4 sales
9
Latest Aug 24, 2026
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • OCULOCULAR THERAPEUTIX, INCChief Scientific Officer

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale OCULRoutine
    May 23, 2025 2025

    Sold 3,024 shares at $7.18 ($22k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 1.1% of holdings ($1.9M position)262,974 shares leftFollows a Form 144Filing

  2. 2 Form 144 notice OCULNotice
    Aug 25, 2025 +94 days

    Filed to sell 3,063 shares ($37k)

    Heier Jeffrey S., Officer

    No 10b5-1 plan1x usual sizeFiling

  3. 3 Form 4 sale OCULRoutine
    Aug 25, 2025 same day

    Sold 3,063 shares at $12.04 ($37k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 1.2% of holdings ($3.2M position)259,911 shares left1x usual sizeFollows a Form 144Filing

  4. 4 Form 4 sale OCULUnusual
    Oct 2, 2025 +38 days

    Sold 10,502 shares at $11.04 ($116k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 4% of holdings ($2.9M position)249,409 shares left3.5x usual sizeFiling

  5. 5 Form 4 sale OCULRoutine
    Nov 24, 2025 +53 days

    Sold 3,469 shares at $12.04 ($42k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 1.4% of holdings ($3M position)245,940 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale OCULRoutine
    Feb 23, 2026 +91 days

    Sold 3,057 shares at $8.28 ($25k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 0.9% of holdings ($2.7M position)323,368 shares left1x usual sizeFiling

  7. 7 Form 4 sale OCULRoutine
    May 26, 2026 +92 days

    Sold 3,018 shares at $8.20 ($25k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 0.9% of holdings ($2.7M position)320,350 shares left1x usual sizeFiling

  8. 8 Form 4 sale OCULRoutine
    Aug 24, 2026 +90 days

    Sold 3,296 shares at $10.78 ($36k)

    Heier Jeffrey S., Chief Scientific Officer

    10b5-1 planSold 1% of holdings ($3.5M position)318,326 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Heier Jeffrey S.
Source
Aug 24, 2026Aug 26, 2026OCULChief Scientific OfficerForm 4 sale3,296$36k1.0%RoutineSEC
May 26, 2026May 28, 2026OCULChief Scientific OfficerForm 4 sale3,018$25k0.9%RoutineSEC
Feb 23, 2026Feb 25, 2026OCULChief Scientific OfficerForm 4 sale3,057$25k0.9%RoutineSEC
Nov 24, 2025Nov 26, 2025OCULChief Scientific OfficerForm 4 sale3,469$42k1.4%RoutineSEC
Oct 2, 2025Oct 6, 2025OCULChief Scientific OfficerForm 4 sale10,502$116k4.0%UnusualSEC
Aug 25, 2025Aug 27, 2025OCULChief Scientific OfficerForm 4 sale3,063$37k1.2%RoutineSEC
Aug 25, 2025Aug 25, 2025OCULOfficerForm 144 notice3,063$37kNoticeSEC
May 23, 2025May 27, 2025OCULChief Scientific OfficerForm 4 sale3,024$22k1.1%RoutineSEC
May 23, 2025May 23, 2025OCULOfficerForm 144 notice3,024$22kNoticeSEC
Feb 24, 2025Feb 26, 2025OCULChief Scientific OfficerForm 4 sale3,061$21k1.1%RoutineSEC
Feb 24, 2025Feb 24, 2025OCULOfficerForm 144 notice3,061$21kNoticeSEC
Nov 25, 2024Nov 27, 2024OCULChief Scientific OfficerForm 4 sale2,948$27k1.1%RoutineSEC
Nov 25, 2024Nov 25, 2024OCULOfficerForm 144 notice2,948$27kNoticeSEC